Poly(ADP-ribosylation) processing as a target for the anti-tumor effects of the cell differentiating agent, hexamethylenebisacetamide, and the N6-substituted adenosines.

Source:http://linkedlifedata.com/resource/pubmed/id/1806031

Download in:

View as

General Info

PMID
1806031